ALEMBIC
Back to Cashflow Statement
|
ALEMBIC Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹-58 Cr | ₹-48 Cr | ₹-46 Cr | ₹-5.82 Cr | ₹-15 Cr |
What is the latest Cash Flow from Financing Activities ratio of ALEMBIC ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2025 | ₹-58 Cr |
Mar2024 | ₹-48 Cr |
Mar2023 | ₹-46 Cr |
Mar2022 | ₹-5.82 Cr |
Mar2021 | ₹-15 Cr |
How is Cash Flow from Financing Activities of ALEMBIC Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2025 | ₹-58 Cr | Negative | |
Mar2024 | ₹-48 Cr | Negative | |
Mar2023 | ₹-46 Cr | Negative | |
Mar2022 | ₹-5.82 Cr | Negative | |
Mar2021 | ₹-15 Cr | - |
Compare Cash Flow from Financing Activities of peers of ALEMBIC
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
ALEMBIC | ₹2,953.2 Cr | -2.5% | 0.5% | -18.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹407,551.0 Cr | 0.4% | 1.8% | 4.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹175,704.0 Cr | -1.1% | 0.1% | 45.6% | Stock Analytics | |
CIPLA | ₹123,675.0 Cr | 3.8% | 1.2% | -1.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹121,925.0 Cr | 2.2% | 11.7% | 11.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹106,626.0 Cr | 1.4% | -3.3% | -7.2% | Stock Analytics |
ALEMBIC Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
ALEMBIC | -2.5% |
0.5% |
-18.8% |
SENSEX | -0.4% |
-1.6% |
1.3% |
You may also like the below Video Courses